NL8802634A - Therapeutische preparaten. - Google Patents

Therapeutische preparaten. Download PDF

Info

Publication number
NL8802634A
NL8802634A NL8802634A NL8802634A NL8802634A NL 8802634 A NL8802634 A NL 8802634A NL 8802634 A NL8802634 A NL 8802634A NL 8802634 A NL8802634 A NL 8802634A NL 8802634 A NL8802634 A NL 8802634A
Authority
NL
Netherlands
Prior art keywords
benzo
ylidene
methoxy
acetic acid
compounds
Prior art date
Application number
NL8802634A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878725009A external-priority patent/GB8725009D0/en
Priority claimed from GB888803908A external-priority patent/GB8803908D0/en
Priority claimed from GB888820347A external-priority patent/GB8820347D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8802634A publication Critical patent/NL8802634A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8802634A 1987-10-26 1988-10-26 Therapeutische preparaten. NL8802634A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB878725009A GB8725009D0 (en) 1987-10-26 1987-10-26 Organic compounds
GB8725009 1987-10-26
GB888803908A GB8803908D0 (en) 1988-02-19 1988-02-19 Improvements in/relating to organic compounds
GB8803908 1988-02-19
GB8820347 1988-08-26
GB888820347A GB8820347D0 (en) 1988-08-26 1988-08-26 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
NL8802634A true NL8802634A (nl) 1989-05-16

Family

ID=27263645

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8802634A NL8802634A (nl) 1987-10-26 1988-10-26 Therapeutische preparaten.

Country Status (15)

Country Link
US (2) US4956381A (ja)
EP (1) EP0319463A3 (ja)
JP (1) JPH01146819A (ja)
KR (1) KR890012646A (ja)
AU (1) AU616215B2 (ja)
BE (1) BE1005157A3 (ja)
CH (1) CH680112A5 (ja)
DE (1) DE3836329A1 (ja)
DK (1) DK593088A (ja)
FR (1) FR2622106B1 (ja)
GB (1) GB2211407B (ja)
HU (1) HU203198B (ja)
IT (1) IT1224594B (ja)
NL (1) NL8802634A (ja)
SE (1) SE8803793A0 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880610A (en) * 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
GB9010332D0 (en) * 1990-05-09 1990-06-27 Sandoz Ltd Improvements in or relating to organic compounds
JP3623501B2 (ja) * 1991-10-31 2005-02-23 ザ ビクトリア ユニバーシティ オブ マンチェスター インターロイキン−１阻害化合物による神経病学的状態の治療
JP3286831B2 (ja) * 1996-04-01 2002-05-27 エーザイ株式会社 ビタミンｂ２含有医薬
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
WO2002074313A1 (en) * 2001-03-21 2002-09-26 Eisai Co., Ltd. Drugs containing reduced vitamin b¿2?
US8752545B2 (en) 2011-02-11 2014-06-17 Batmark Limited Inhaler component
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
BR112014004818B1 (pt) 2011-09-06 2021-01-05 British American Tobacco (Investments) Limited. aparelho para aquecer material fumável e método para aquecer material fumável
EP2753202B1 (en) 2011-09-06 2016-04-27 British American Tobacco (Investments) Ltd Heating smokeable material
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
CA3103090C (en) 2016-04-27 2023-03-28 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195800B (en) * 1983-10-13 1988-07-28 Sandoz Ltd Process for producing 4h-benzo/4,5/cylopenta/1,2-b/ thiofene derivatives and pharmaceutical compositions containing them
GB8530245D0 (en) * 1985-12-09 1986-01-22 Sandoz Ltd Organic compounds
US4692460A (en) * 1986-12-24 1987-09-08 Mcneilab, Inc. Cyclopenta[b]thiophenes having anti-inflammatory activity similar to steroids

Also Published As

Publication number Publication date
IT1224594B (it) 1990-10-04
GB2211407B (en) 1991-10-16
HUT51485A (en) 1990-05-28
US4956381A (en) 1990-09-11
EP0319463A3 (en) 1990-10-10
GB8824887D0 (en) 1988-11-30
FR2622106A1 (fr) 1989-04-28
AU616215B2 (en) 1991-10-24
BE1005157A3 (fr) 1993-05-11
SE8803793A0 (sv) 1989-04-27
US5096921A (en) 1992-03-17
KR890012646A (ko) 1989-09-18
CH680112A5 (ja) 1992-06-30
FR2622106B1 (fr) 1992-07-10
IT8848491A0 (it) 1988-10-26
HU203198B (en) 1991-06-28
DK593088A (da) 1989-04-27
SE8803793D0 (sv) 1988-10-24
DK593088D0 (da) 1988-10-25
JPH01146819A (ja) 1989-06-08
DE3836329A1 (de) 1989-05-03
EP0319463A2 (en) 1989-06-07
AU2417588A (en) 1989-04-27
GB2211407A (en) 1989-07-05

Similar Documents

Publication Publication Date Title
NL8802634A (nl) Therapeutische preparaten.
RU2048812C1 (ru) Способ лечения воспалительных заболеваний глаза и средство для лечения воспалительных заболеваний глаза
KR101296561B1 (ko) 도파민성 뉴런의 소실을 치료하거나 예방하기 위한로티고틴의 용도
JPH07206676A (ja) 糖尿病の治療用薬剤
KR20070116632A (ko) 프로스타글란딘 Ｆ２ａ 유도체를 유효 성분으로서 함유하는망막신경세포 보호제
PT1392355E (pt) Utilização de inibidores do proteassoma para tratar distúrbios associados à secura ocular
KR20160012184A (ko) 뉴런 세포에서의 단백질 응집체 침착을 특징으로 하는 질환을 치료하는데 사용하기 위한 타크롤리무스
AU2002308760A1 (en) Use of proteasome inhibitors to treat dry eye disorders
CN114555577A (zh) 用于治疗门静脉炎症和纤维化的噻吩衍生物
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
JP3363440B2 (ja) 脊髄小脳変性症治療剤および脊髄小脳変性症治療用組成物
CA2207943A1 (en) Therapeutic agent for joint diseases
JPH10316574A (ja) ドライアイ治療剤
EP0914122B1 (en) Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
US6576668B1 (en) Remedies for arthrosis deformans
US20220378866A1 (en) Combination therapy methods, compositions and kits
WO2000037089A1 (en) Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
JP3873181B2 (ja) 変形性関節症治療剤
US20160120853A1 (en) Tacrolimus and analogues thereof for medical use
JP2000336042A (ja) 眼圧下降剤
JPH11255648A (ja) 血管新生阻害剤
GB1585630A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
BV The patent application has lapsed